Innate Pharma Presents Initial Phase 1 Clinical Data for IPH4502 at ENA 2026

MARSEILLE, France–(BUSINESS WIRE)– #ADC–Innate Pharma presents initial Phase 1 clinical data for IPH4502 at ENA 2026

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.